Chise Tateno-Mukaidani

Chief Tech/Sci/R&D Officer presso PHOENIXBIO CO., LTD.

Patrimonio netto: 49 683 $ in data 31/03/2024

62 anni

Commercial Services

Process Industries

Profilo

Chise Tateno-Mukaidani is currently the Managing Director and Manager of Research & Development at PhoenixBio Co., Ltd.
since 2014.
Additionally, Dr. Tateno-Mukaidani is also currently serving as the Chief Scientific Officer at PhoenixBio USA Corp.
since 2012.
Previously, Dr. Tateno-Mukaidani worked as a Principal at Sumitomo Chemical Co., Ltd.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
PHOENIXBIO CO., LTD. 0.39%	31/03/2023	15 600 ( 0.39% )	49 683 $	31/03/2024

Posizioni attive di Chise Tateno-Mukaidani

Società	Posizione	Inizio
PHOENIXBIO CO., LTD.	Chief Tech/Sci/R&D Officer	01/04/2007
PhoenixBio USA Corp. PhoenixBio USA Corp. Miscellaneous Commercial ServicesCommercial Services Part of PhoenixBio Co., Ltd., PhoenixBio USA Corp. develops technologies for mass propagation of human cells into laboratory animals. The private company is based in New York, NY. Yoshio Morikawa has been the CEO of the company since 2015.	Corporate Officer/Principal	01/06/2012

Tutte le posizioni attive di Chise Tateno-Mukaidani

Precedenti posizioni note di Chise Tateno-Mukaidani

Società	Posizione	Fine
SUMITOMO CHEMICAL CO., LTD.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Chise Tateno-Mukaidani

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Chise Tateno-Mukaidani

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
SUMITOMO CHEMICAL CO., LTD.	Process Industries
PHOENIXBIO CO., LTD.	Commercial Services

Aziende private	1
PhoenixBio USA Corp. PhoenixBio USA Corp. Miscellaneous Commercial ServicesCommercial Services Part of PhoenixBio Co., Ltd., PhoenixBio USA Corp. develops technologies for mass propagation of human cells into laboratory animals. The private company is based in New York, NY. Yoshio Morikawa has been the CEO of the company since 2015.	Commercial Services

Vedi le connessioni aziendali